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Abstract: Polyhydroxybutyrate (PHB) is a polymer used to restore tissues or regenerate bones. However, its compatibility with human
bone marrow-derived mesenchymal stem cells (MSCs) has not been examined. PHB membranes of random (r-PHB) or aligned (a-PHB)
electrospun nanofibers that generate bone and spinal axon scaffolds were combined with human MSCs. The adhesion and proliferation
of cells on these membranes were examined. The orientation of cells on PHB membranes was analyzed by confocal microscopy
and scanning electron microscopy (SEM). The MSCs maintained their characteristic properties on the membranes, adhered to the
membranes, and preserved their viability. The cell morphology was different when they were grown on differentially designed matrices.
Cells expanded on the a-PHB membrane and showed fibroid-like morphology. Conversely, cells interacting with the r-PHB membrane
were located homogeneously and demonstrated polygonal morphology. The adhesion and proliferation of human MSCs was higher on
the a-PHB membrane than on the randomly oriented one. Fiber orientation influenced the phenotype and biological behavior of human
MSCs. This property may be useful in the selection of specifically designed scaffolds for the desired tasks. The results of this preliminary
study indicated that PHB membranes designed for bone or nerve tissue engineering are compatible with human MSCs.
Key words: Polyhydroxybutyrate, electrospinning, bone marrow, mesenchymal stem cell, biocompatibility, tissue engineering

1. Introduction
Scaffolds are used to aid in tissue engineering and to
provide appropriate micro- and macroenvironments for
cell expansion and/or differentiation to enhance recovery.
Many types of scaffolds have been fabricated and designed
for tissue engineering, such as membranes, fabric, spongelike scaffolds, and gels. Electrospinning is the simplest
method to create a porous scaffold by random or aligned
arrangement of nano- or microfibers (McLane et al., 2013;
Yu et al., 2013). Several scaffolds were reported to have
many outstanding properties (e.g., high porosity) that
mimic those of the extracellular matrix (Takahashi and
Tabata, 2003; Li et al., 2005). Modification of the surface
properties of biomaterials is important for controlling
the biological activities of cells such as cell adhesion,
migration, proliferation, and differentiation (Palmquist
et al., 2010). On the other hand, this process is highly
regulated by the extracellular microenvironment and
the cell type (Lutolf and Hubbell, 2005). Recently, there
* Correspondence: sevilarslan@hotmail.com
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has been increasing interest in constructing desirable
extracellular microenvironments on the surface of
biomaterials in order to obtain optimal cell and/or tissue
responses. Studies with polyhydroxybutyrate (PHB)
membranes and mesenchymal stem cells (MSCs), which
have high differentiation capacity, showed that PHB
membranes induced MSCs to osteogenic differentiation in
vitro and in vivo (Wang et al., 2004; Wollenweber et al.,
2006; Rentsch et al., 2010)
PHB is the most thoroughly investigated member of
the PHA family and has shown good biocompatibility
with different cell types, including mouse fibroblast cell
lines (Yang et al., 2002), chondrocytes (Saito et al., 1991),
osteoblasts (Köse et al., 2003a, 2003b), endothelial cells
(Shishatskaya and Volova, 2004), and gastrointestinal cells
in rats (Freier et al., 2002). Although PHB is inherently
biodegradable and biocompatible, the use of PHB is
significantly limited in biomedical applications due to
several characteristics, such as brittleness, rigidity, and low
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mechanical properties (Engelberg and Kohn, 1991; Misra
et al., 2006). Studies have shown that the degradation
rate of PHB in vitro and in vivo is slow relative to that
of biodegradable polymers such as poly(lactic acid),
poly(glycolic acid), and polydioxanone (Yasin and
Tighe, 1992). It has been evaluated as a suitable material
in medicinal applications, including controlled release
systems, wound dressings, surgical sutures, orthopedic
devices, tissue engineering, and skin substitute materials
(Galego et al., 2000; Chen and Wu, 2005; Wu et al., 2009).
In vitro studies with PHB scaffolds for nerve tissue
engineering showed that PHB membranes induced neural
progenitor cells and embryonal cell lines to neuronal
differentiation (Xu et al., 2010; Khorasania et al., 2011).
PHB scaffolds have been used as a guidance channel in in
vivo studies. PHB scaffolds supported nerve survival and
axonal regeneration in both spinal cord and peripheral
nerves (Novikov et al., 2002; Young et al., 2002; Novikova
et al., 2008).
Two studies focused on the compatibility of MSCs with
PHB. These studies revealed that poly (3-hydroxybutyrateco-3-hydroxyhexanoate) stimulated MSC attachment and
growth (Hu et al., 2009) and osteogenic differentiation
(Wei et al., 2009). A recent study confirmed that peptidefunctionalized and aligned PHB nanofibrous scaffolds may
serve as a potential scaffold for Schwann cell regeneration
(Masaeli et al., 2014). Fiber orientation is assumed to
influence the phenotype and genotype of MSCs on PHA
matrices. Aligning PHA nanofibers using electrospinning
is a new approach, and its outcomes, when combined with
MSCs, are less studied.
The continuous proliferative capacity of MSCs,
their differentiation potential, and their cell surface
molecule changes have not been previously investigated.
The present study investigated whether human MSCs
grown on nanoscaled PHB scaffolds would retain their
morphological characteristics and regenerative features.
Furthermore, we explored whether random (r-PHB) and
aligned (a-PHB) nanofibrous PHB membranes would
change the phenotype and features of these cells. The aim
of the present study was to characterize the interactions
of r-PHB and a-PHB electrospun nanofibers with human
MSCs by evaluating their viability, adhesion, continuous
proliferation, differentiation, and apoptosis capacity.
2. Materials and methods
2.1. Preparation and characterization of PHB scaffolds
Commercially available PHB (Sigma-Aldrich, Catalog
number: 29435-48-1) was dissolved in chloroform at a
concentration of 5% (w/v). Using a syringe pump, the PHB
solution was fed at a rate of 0.1 mL/h through a syringe.
The distance between the tip of the syringe and the
rotating collector was 20 cm. A high voltage power supply

(Spellman CZE1000R) was used to apply a positive voltage
of 11 kV DC to produce PHB nanofibers.
The PHB solution was fed into the center of the
rotary concentrator, where it was randomly distributed,
resulting in randomly oriented fibers. This central area
was surrounded by a circular area of approximately 3
cm, which consisted of both random and aligned fibers
and was not used in the study. The outer border of the
collector contained aligned fibers only and was used for
comparison. Samples from the central area (with random
configuration) and the outer border (with aligned fibers)
were selected by scanning electron microscopy (SEM).
The conditions for electrospinning were optimized in
order to obtain a continuous process and reproducible
mesh morphology. A nanoscaled regular fibrillar
surface property was obtained on the membranes. The
morphology of electrospun PHB nanofibers was assessed
and their diameter was measured under an SEM (ZEISS
EVO 50 EP and ZEISS SUPRA 50 VP).
2.2. Isolation and characterization of MSCs
Human MSCs were obtained from three healthy bone
marrow transplantation donors with an average age of 32.
The use of human MSCs in the present study was approved
by the Ethics Committee of Hacettepe University (Ankara/
Turkey, TBK 09/15-194). Informed consent was obtained
from all donors. Mononuclear cells (MNCs) were
isolated from human bone marrow by density gradient
centrifugation using a Ficoll solution (Biocoll; density
1.077 g/mL, Biochrom AG). The harvested MNCs were
transferred into tissue culture flasks containing Dulbecco’s
modified Eagle’s medium (DMEM; Gibco) supplemented
with 10% (v/v) fetal bovine serum (FCS; Gibco) and 1%
(v/v) antibiotics (10.000 U/mL penicillin and 10.000 µg/
mL streptomycin; Biochrom AG) and incubated at 37 °C
under an atmosphere of 5% CO2. The culture medium was
changed every 3 to 4 days until the primary adherent cells
reached subconfluency. The confluent cells were routinely
subcultured by trypsinization. Only passage 3–4 cells were
used in the present study.
Third passage human MSCs were characterized
with respect to the expression of surface antigens and
differentiation assays. Experiments were performed in
duplicate. For fluorescence-activated cell sorting (FACS),
cells were trypsinized and incubated for 20 min in dark at
room temperature with 5 µL of fluorochrome-conjugated
monoclonal antibody (BD Pharmingen and eBioscience).
Cells were analyzed for negative expression of
hematopoietic (CD 34 and CD 45) and positive expression
of mesenchymal (CD 90, CD 105, CD 73, CD 44, and
CD 49e) cell surface markers. Cells were analyzed with a
FACSAria flow cytometer (Becton Dickinson) using v6.1.2
software with 10,000 events recorded for each sample.
For differentiation analysis, osteogenic and adipogenic
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differentiations of human MSCs were induced by
culturing the cells in an osteogenic (DMEM-LG, 10% FCS,
100 nM dexamethasone, 10 mM beta glycerophosphate
(AppliChem), and 0.2 mM L-ascorbic acid (Sigma)) or
an adipogenic differentiation reagent (DMEM-LG, 10%
FCS, 1 µM dexamethasone (Sigma), 60 µM indomethacin
(Sigma), 0.5 mM isobutylmethylxanthine (Sigma), and 50
µM indomethacin). The media were refreshed every 3 to
4 days.
2.3. Cell viability and proliferation on PHB scaffolds
2.3.1. MTT assay
The tetrazolium dye (MTT) colorimetric assay was used
to examine the number of attached cells on the PHB
scaffolds. Membranes were cut into small, 0.31-cm2 pieces
and specimens were placed in wells of 96-well culture
plates. MSCs were seeded at a concentration of 1 × 104
cells/scaffold and cultured for 2, 5, 7, 9, 11, and 13 days.
The scaffolds were transferred to a fresh 96-well culture
plate and 5 mg/mL MTT (Sigma-Aldrich) solution was
used in the MTT assay to test cell viability. Absorbance
was read at 620 nm (Tecan).
2.3.2. Real time cell proliferation analysis
Using the xCELLigence system (Roche Applied Science
and ACEA Biosciences) we analyzed cell proliferation
using label-free and real-time monitoring. For this
experiment, human MSCs were seeded at a concentration
of 2 × 105 cells per scaffold and were cultured for 14 days for
confluency. Then cells were removed from the membranes
and seeded on an e-plate. Cell impedance was monitored
for 10 days and impedance was measured every hour.
2.3.3. Growth kinetics experiment
PHB membranes were cut into 3.8-cm pieces and placed
in individual wells of 12-well culture plates in order to
generate a growth curve of human MSCs. MSCs were
seeded at 5 × 104 cells per membrane and were cultured.
The scaffolds were placed in a fresh 6-well culture plate for
3, 5, 7, and 10 days and cells were harvested and counted
using trypan blue dye.
2.3.4. SEM
SEM was performed 5 and 10 days after cultivation.
Cells were washed with PBS buffer and fixed with 2%
glutaraldehyde solution (Sigma Aldrich) at 4 °C for 1
h. The samples were washed with PBS and dehydrated
in a series of ethanol (25%, 50%, 75%, 95%, and 100%).
The membranes were sputter-coated with platinum and
examined using an SEM (ZEISS EVO 50 EP).
2.3.5. Confocal laser scanning microscopy (CLSM)
Cells were incubated with 5 µL/mL lipophilic dye (Vybrant
DiO dye, Invitrogen) and seeded at 7 × 105 per scaffold.
CLSM was performed on day 5 and day 10. Viable human
MSCs retained the lipophilic label. Following cultivation,
the membranes were placed in a confocal microscopy plate
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(MatTek Corporation). Fluorescent-labeled cells were
observed under a confocal microscope, LSM 510 (LSM
Pascal, Zeiss), and analysis was performed with Zeiss LSM
Image Browser software.
2.4. Evaluation of MSC characteristics on PHB scaffolds
2.4.1. Differentiation capacity
MSCs were seeded at a concentration of 5 × 103 cells/scaffold
and cultured for 10 days. The differentiation analysis was
performed after 21 days. For adipogenic differentiation,
the cells were fixed with 10% buffered formalin; 0.3% Oil
Red O (Sigma Aldrich) was used to detect intracellular
lipid accumulation. For quantitative analysis, the stains
were solubilized using 2% IGEPAL in isopropanol (v/v);
the resulting absorbance was measured at 492 nm. For
osteogenic differentiation, 0.6% M HCl was added to the
cells. The amount of calcium was quantitatively measured
with QuantiChrom Calcium Assay Kit (Bioassay Systems)
and absorbance was measured at 620 nm.
2.4.2. Cell surface markers
MSCs were seeded at a concentration of 1 × 105 cells/
scaffold and were cultured for 10 days. The membranes
were placed to a fresh 6-well culture plate for the indicated
time intervals (3, 5, 7, and 10 days) and cells were
harvested and counted. Cells were trypsinized in order to
obtain a cell suspension, and then incubated for 20 min in
the dark at room temperature with 5 µL of fluorochromeconjugated monoclonal antibody (BD Pharmingen and
eBioscience). Cells were analyzed with different surface
markers, including CD 105, CD 271, CD 90, ALP, CD 73,
CD 29, and CD 49e. Following incubation with the specific
antibody, cells were washed and analyzed with a FACSAria
flow cytometer (Becton Dickinson) and BD FACSDiva
using v6.1.2 software with 10,000 events recorded for each
sample.
2.5. Statistical analysis
All statistical analyses were performed using SPSS 21
(IBM SPSS 21.0 for Windows). Multiple comparisons
were performed using the Kruskal–Wallis test. The Mann–
Whitney U test was used for pairs. Descriptive statistics
were presented as median and minimum and maximum
values. The confidence interval was 95%.
3. Results
3.1. Characterization of PHB scaffolds
The electrospun PHB membranes were analyzed for surface
topology. The electrospun surfaces ultrastructurally
exhibited regularly arranged aligned nanofibers following
a parallel direction. Figure 1 shows that the fiber diameter
was about 700–900 nm. As shown in Figure 2, fibers were
aligned in the outer periphery of the rotary concentrator
and randomly distributed in the center. Between 80% and
90% of the a-PHB electrospun nanofibers were aligned
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Figure 1. SEM images of PHB fibers.

A

B

Figure 2. SEM images of aligned (A) and random PHB membranes (B).

the same way (Figure 1). This structure was similar to
the natural extracellular matrix of most human regular
connective tissues. Additionally, bead formation was not
observed (Figures 1 and 2)
3.2. Characterization of human MSCs
The criteria proposed by the International Society for
Cellular Therapy for MSC characterization were taken
into consideration for the characterization of human
MSCs (Dominici et al., 2006). In vitro culture-expanded
human bone marrow MSCs showed plastic adherent
and ﬁbroblastic morphology (data not shown). The
immunophenotyping analysis of the MSCs revealed
positive immunolabeling for CD 105, CD 44, CD 73, CD
49e, and CD 90 surface antigens, and negative labeling for
hematopoietic markers, including CD 45 and CD 34 (data
not shown). These morphological and immunophenotypic
characteristics conﬁrmed the stromal and multipotential
nature of our cells.

3.3. Cell viability and proliferation on PHB scaffolds
The number of cells on the a-PHB membrane was higher
than that on the r-PHB membrane on all days of the MTT
cell viability assay analysis (Figure 3). The proliferation
rate of MSCs was higher on the aligned membrane at
the beginning of culture, but the viable cell number was
higher on the r-PHB membrane at the end of the culture
period. Population doubling analysis of human MSCs
at the end of days 3, 5, 7, and 10 of culture on the two
types of membranes demonstrated lower human MSC
proliferation on both membranes as compared with that of
the control cells (P < 0.05) (Figure 4).
Real time cell proliferation analysis using the
xCELLigence system showed that the growth curves of the
a-PHB and r-PHB membrane-incubated human MSCs were
slightly lower than the growth curve of the controls, but they
were close to each other for 10 days (Figure 5). Those results
were confirmed by the MTT and population doubling assays.
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Figure 3. MTT assay of human MSCs reveals a higher cellular proliferation rate on the
aligned PHB membrane than on the random PHB membrane.
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Figure 4. Population doubling assay of human MSCs on the aligned PHB
membrane (red bars) and the random PHB membrane (green bars) as
compared with control cells (blue bars).

3.4. Cell morphology on PHB scaffolds
DiO-labelled live cells proliferated homogeneously on the
whole surface by making aligned rows on aligned fibers
(Figures 6 and 7). The cells exhibited spindle-shaped
morphology on the a-PHB surface, but had polygonal
appearance and expanded at unequal intervals and
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nonhomogeneously on the r-PHB surface on both day 5
and day 10 (Figures 6 and 7). Similar results were obtained
by SEM analysis. Human MSCs expanded for 5 days on
the a-PHB membrane were ultrastructurally aligned
parallel to the direction of oriented nanofibers and were
spindle-shaped. On day 10 of analysis, increased numbers
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Figure 5. The green line shows the growth curve (cell index) of control cells; the red line shows the human MSCs expanded on the
a-PHB membrane; and the blue line shows the human MSCs expanded on the r-PHB membrane.

A

B

Figure 6. Confocal microscope analysis reveals spindle-shaped morphology of aligned
organization of human MSCs on the a-PHB membrane (A) and their polygonal shape
and clustered organization on the r-PHB membrane (B) on day 10.

A

B

Figure 7. SEM analysis of aligned organization of human MSCs on the a-PHB membrane
(A) and their polygonal shape organization on the r-PHB membrane (B).

of aligned human MSCs making intercellular connections
were observed. Human MSCs expanded from 5 to 10
days on the r-PHB membrane made clusters or spread

homogeneously and exhibited polygonal morphology
(Figures 6 and 7).
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3.5. Cell characters and differentiation capacity on PHB
scaffolds
3.5.1. Adipogenic and osteogenic differentiation capacity
MSCs differentiated into adipogenic and osteogenic cells on
both PHB membranes. Figure 8 shows the morphological
analysis of human MCS adipogenic cell differentiation
on the a-PHB fabric. Quantitative analysis of adipogenic
differentiation revealed that the differentiation rate of cells
on the a-PHB membrane was 63.6%, which was higher
than that of cells on the r-PHB membrane (9.8%) (Figure

9). Quantitative analysis of osteogenic differentiation
revealed that human MSCs expanded on the a-PHB
membrane displayed increased osteogenic differentiation
capacity (156.2%) in comparison with those expanded on
the r-PHB membrane (132.2%) (Figure 9).
3.5.2. Cell surface markers
MSCs expanded on both PHB membranes and their
surface molecule expression patterns were similar to those
of the control human MSCs. The Table shows the human
MSC surface markers analyzed by flow cytometry. CD
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Table. Cell surface marker percentages of control cells and cells expanded on the a-PHB and r-PHB membranes.
Surface marker

Control cells

Cells on the a-PHB membrane

Cells on the r-PHB membrane

HLA-DR

0.7%

3.2%

3.4%

CD271

0.7%

0.5%

0.5%

ALP

0.2%

0.2%

0.3%

CD 106

1.0%

1.1%

0.8%

CD 105

87.9%

91.2%

88.6%

CD 90

99.4%

99.6%

99.3%

CD 49e

80.4%

86.9%

84.2%

CD 73

62.6%

62.8%

69.6%

CD 29

95.4%

97.1%

96.7%

CD 44

72.2%

86.8%

72.4%

105, CD 44, CD 73, CD 49e, and CD 90 surface antigens
were positive, while hematopoietic markers, including CD
45 and CD 34, were negative, as expected. This analysis
showed that the PHB membranes did not affect the stem
cell surface marker expression of human MSCs.
4. Discussion
Here we demonstrated the biocompatibility of PHB
membranes with human bone marrow-derived MSCs using
viability, proliferation, characterization, and morphology
with confocal microscopy and SEM. Through a series
of morphological, biochemical, and semiquantitative
analyses, we demonstrated that nanofibrous PHB
membranes with two different topographies have positive
interactions with human MSCs. To evaluate a new type of
scaffold for nerve and bone regeneration, the evaluation
of physical and cell growth properties is important
and in vitro cell culture studies are required to carry
a new material to the stage of animal testing. This PHB
scaffold has promising properties (e.g., biocompatibility,
biodegradability, excellent physical properties, and
excellent cell survival and growth responses).
The PHB membranes were produced using the
electrospinning method. Viability assays (MTT,
population doubling, and confocal microscopy) showed
that cells on the PHB membranes had lower adhesion,
but similar viability when compared with control cells.
Proliferation was analyzed directly with the xCELLigence
system. The results showed that the scaffold cells had a
proliferation rate similar to that of the control cells. The
characteristic features of the cells were also studied. The
scaffold cells showed less adipogenic differentiation and
more osteogenic differentiation than the control cells. The
surface markers of the scaffold cells were found to be similar

to those of the control cells. Morphological examinations
by confocal microscopy showed good communication
between the human MSCs and the PHB scaffolds and a
high rate of cell expansion on day 10. Histological analysis
revealed that human MSCs on the a-PHB scaffold had
spindle-shaped morphology and were located parallel to
the fibrils; however, cells on the r-PHB scaffold showed
polygonal morphology in the spaces.
This in vitro study, which examined different aspects
of the interaction between bone marrow-derived
human MSCs and PHB scaffolds, can be improved
with immunohistochemical analysis to check the MSC
expression profile of the extracellular matrix production.
Further examinations need to be performed, including
evaluation of the in vivo biocompatibility of PHB
membranes with nerve and bone tissues at the molecular
level. However, prior to in vivo administration, the in
vitro immunogenic and inflammatory properties of MSCs
should be examined in detail.
In previous studies, PHB nanofiber membrane
diameters were obtained in the range of 100–680 nm
by the electrospinning method (Sangsanoh et al., 2007;
Suwantong et al., 2007; Li et al 2008; Asran et al., 2010).
Here we found that the PHB nanofiber diameter was about
700–900 nm, which is an average value according to the
literature. In the literature, the viability of different cell
types on PHB scaffolds is analyzed. As mentioned before,
limited analyses of the interaction between PHB and
MSCs have been undertaken. Yu et al. (2010) investigated
the viability and metabolic activity of human MSCs grown
on various PHA films, including PHB, and found that the
metabolic activity of human MSCs on PHB membranes
was similar to that of the control cells. In another study,
the vitality of fibroblasts grown on PHB scaffolds was

417

KÖSE et al. / Turk J Biol
evaluated by MTT assay; although cell toxicity was found
to be about 10%, cell adhesion was very low (Suwantong
et al., 2007). Wollenweber (2006) demonstrated that
osteogenic differentiation of human MSCs interacting
with PHB membranes increased as compared with
that of control cells, and exhibited good viability after
differentiation. In a similar study consisting of both in vitro
and in vivo experiments, human MSCs presented excellent
adhesion and expansion on PHB membranes. In in vivo
experiments, 6 months after subcutaneous implantation
in rats, human MSCs implanted with PHB membranes
exhibited increased alkaline phosphatase activity and
calcium content as compared with control cells (Rentsch

et al., 2010). In our study, we obtained better adhesion
and viability results for human MSCs with both types of
PHB scaffolds in different qualitative and quantitative
proliferation assays.
PHB membranes were successfully produced using the
wet electrospinning method with a nanosize fiber diameter.
The PHB membrane provided a suitable surface for the
adhesion, proliferation, expansion, and differentiation
of human MSCs. These results suggest that the PHB
membrane has good potential as a scaffold for spinal cord
and bone tissue engineering of MSCs. However, in vivo
animal model studies are needed to assess the suitability of
nanofibrous PHB membranes.
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